Bethyl Laboratories
Mouse anti-Taq Polymerase Recombinant Monoclonal Antibody [TP7]
Monoclonal Antibodies
Catalog #A700-278-T
TargetTaq Polymerase
HostMouse
CloneTP7
ReactivitySpecies Independent
ApplicationHotStart PCR
Image 1 of 2
local_shipping
Order within 6 hours and 55 minutes for shipment by Tuesday, November 24
Product Description
Taq Polymerase is a heat-stable enzyme originally identified in Thermus aquaticus that is used in the polymerase chain reaction (PCR), a technique often utilized in modern molecular biology. When combined with appropriate concentrations of dNTPs and template DNA, the enzyme is capable of polymerizing de novo strands of DNA at relatively high temperature. The enzyme does have some baseline activity at lower temperatures, leading to inappropriately short contaminant DNA. This can be remedied by adding an antibody against Taq, which inhibits its activity. The antibody’s binding activity is lost at the optimal temperature for Taq activity.
Specifications
Clonality
Recombinant Monoclonal
Clone
TP7
Host
Mouse
Immunogen
Taq-Polymerase
Isotype
IgG2a
Reactivity
Species Independent
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Purified
Concentration
1000 µg/ml
Target Identity
TargetTaq Polymerase
Product Information
Applications
HotStart PCR
Buffer
Phosphate Buffered Saline (PBS) with 0.1% BSA and 0.09% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Recombinant antibody was purified from cell culture supernatant.
Immunogen was Taq polymerase.
Applications
HotStart PCR1ug of mAb per 5U of Taq
Documents
Product DatasheetPDF · A700-278-T · Lot 1 (current lot)Open
Safety Data SheetPDF · A700-278-TOpen
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



